March 26, 2018 / 8:57 PM / 4 months ago

BRIEF-RXI Says Determined Interim Financial Statements For Qtrs Ended March 31, June 30, Sept 30, 2017 Should No Longer Be Relied Upon‍​

March 26 (Reuters) - Rxi Pharmaceuticals Corp:

* RXI - ON MARCH 20, DETERMINED INTERIM FINANCIAL STATEMENTS FOR QTRS ENDED MARCH 31, JUNE 30, AND SEPT 30, 2017 SHOULD NO LONGER BE RELIED UPON‍​

* RXI PHARMACEUTICALS - ‍ADJUSTMENT IN RESTATED INTERIM FINANCIAL STATEMENTS FOR PRIOR PERIODS IS A NON-CASH CHARGE​

* RXI - ‍ADJUSTMENT IN RESTATED STATEMENTS DID NOT AFFECT PREVIOUSLY REPORTED NET LOSS/OPERATING CASH FLOWS, HAD NO IMPACT ON BALANCE SHEET​

* RXI - CONCLUDED INTERNAL CONTROL DEFICIENCIES SPECIFIC TO ISSUE REPRESENT ‘MATERIAL WEAKNESS’ IN INTERNAL CONTROL OVER FINANCIAL REPORTING​

* RXI - DETERMINED CO'S DISCLOSURE CONTROLS & PROCEDURES WERE NOT EFFECTIVE FOR PRIOR PERIODS​ Source text: [bit.ly/2uk8hHF] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below